Trending Creators in 2025$XTALPI(02228.HK) Since acquiring Liverpool ChiroChem (LLC) in the UK, AiFChem (Jingtai's subsidiary in Massachusetts) has launched a series of high-purity chiral building blocks co-developed based on this technology, covering 45,000+ compounds with purity ≥ 95%.
"LCC's PACE™ automated platform integrates AI software and automation to achieve closed-loop linkage from virtual prediction to physical synthesis." This is also the technological source for AiFChem to provide 45K high-purity chiral building blocks.
It is a top-tier strategic product in the current market
• Leading in scale, purity, and application level;
• Future-oriented (supporting innovative drug discovery tools such as DEL, PROTAC, linkers, etc.);
• Strengthening industry trust and differentiated competitiveness through strict QC.
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
